High-impact AI Executive and Computational Scientist with nearly two decades of international experience bridging cutting-edge scientific R&D with production-grade AI system execution. Proven track record co-leading the end-to-end deployment of enterprise AI services, establishing rigid MLOps/LLMOps governance, and managing cross-continental, multi-disciplinary engineering organizations.
Production-Grade AI Deployments, Autonomous Multi-Agent Workflows, Large Language Models (LLMs), Natural Language Processing (NLP), Deep Learning (CNNs), System Architecture.
MLflow (Model Lifecycle, Registry, & Governance), Dify (Agentic Orchestration & Telemetry), Distributed Systems, High-Performance Computing (HPC), AWS, Azure, Unix/Linux.
C-Suite Stakeholder Alignment, Technology Due Diligence (M&A), Cross-Functional Requirements Mapping, Multi-Modal Big Data Ecosystems (Multiplex Images, Clinical Trials, NGS/Omics).
Advanced: Python, R, C++, C
Intermediate: MATLAB, Java, Perl, SQL, Julia, Spark.
Group Leader & Organization Advisory Board Member — Germany
Scientist & R&D Project Lead — Belgium
Researcher — Italy
Graduate Research Assistant (Paid Appointment) — Germany
University of Bonn (Germany) | 2010 – 2013
Bonn-Aachen International Center for IT & Fraunhofer SCAI | 2007 – 2009
Acharya Institute of Technology (India) | 2002 – 2006
Interactive walk-throughs showcasing custom graphical interfaces, computational architecture runs, and predictive systems biology simulations.
Demonstrating multi-modal network inference capabilities, predictive logic execution, and interactive interface controls for high-dimensional biological data.
An inside look at pipeline execution parameters, showing automated workflow tracking, graph rendering, and data parsing loops.
Micro-essays and quick architectural takes on the evolving intersection of machine learning, computational genomics, and drug discovery workflows.
Single large language models fail when parsing highly dense, multi-omic academic literature due to context dilution and hallucinated pathways. Transitioning to specialized, multi-agent frameworks—where independent agents are isolated to cross-examine target validity, patent spaces, and telemetry data—is yielding drastically cleaner candidate signals.
Despite the massive industry shift toward deep transformer architectures, gradient boosting variants remain the undisputed backbone for sparse, high-dimensional tabular biological matrices. When sample sizes are outpaced by feature counts (e.g., patient transcriptomics), the inductive bias of tree-based partitioning consistently dominates over parameter-heavy neural networks.
Highlights, technical keynotes, community engagement, and creative publications from over 15+ international events and personal archives.
"The barrier to scaling multiomic architectures isn't the compute footprint—it's establishing reproducible spatial telemetry patterns that bridge raw imaging pixels with downstream agentic systems."
Featured domain expert speaker at the international Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) symposium, detailing industrial applications, computational biology architectures, and the evolution of AI frameworks within the life sciences ecosystem.
An architectural critique on data science methodology exploring the systemic dependency on statistical significance limits. Outlining why scaling robust production AI patterns requires moving beyond arbitrary cutoff metrics to holistic decision-making workflows.
Pascal Sempé (@IBM) and Paurush Praveen (@CluePoints) two of our speakers for the afternoon sessions over "Potentialities of artificial intelligence use in drug discovery" and "Potentialities of artificial intelligence use in drug development: clinical research" #AI #wallonia pic.twitter.com/n4XfnQc4vu
— BioWin (@BioWin_asbl) November 28, 2017
Demonstrated elite algorithmic performance by ranking in the Top 10 across two separate DREAM Challenges, solving complex, crowd-sourced biomedical data science problems. Regularly engage with premier global AI communities, including attending NeurIPS, to cross-examine emerging neural architectures and benchmark industrial R&D pipelines against state-of-the-art breakthroughs.
A recorded technical presentation delivering deep architectural insights into heterogeneous biological knowledge integration from multiple sources in Bayesian framework.
An imaginative piece featured on my personal blog site. Writing narratives, creative essays, and speculative fiction acts as a crucial conceptual tool for stretching communication architectures beyond dry documentation into deep, resonant human storytelling layouts.
A timeline tracking over a decade of algorithmic and computational contributions across biomedical domains.
Leading engineering pipelines focused on deep learning computer vision architectures and generative intelligence models purpose-built for the next generation of therapeutics and digital pathology.
Developing models optimized for high-throughput automated cellular segmentation, tissue region identification, and spatial single-cell mapping loops.
Architecting rapid, automated gating algorithms and statistical frameworks for multi-parametric single-cell identification.
Fine-tuning and prompting foundational Large Language Models to read, synthesize, and extract knowledge from unstructured clinical text and molecular corpuses.
Engineered unsupervised statistical anomaly detection algorithms designed to systematically identify, audit, and isolate processing biases and data artifacts across distributed, multi-center clinical trials.
Formulated high-dimensional statistical network frameworks to model, map, and evaluate complex structural composition and ecological dynamics within the human intestinal microbiome.
Constructed predictive disease-progression models by integrating multimodal inputs—unifying pixel-level radiological mapping (MRI/CT scans) with macro-level pathological tissue structures.
Developed a custom Bayesian Framework utilizing Nested Effects Models (NEM) to reconstruct and infer biological signaling network topologies from high-throughput transcriptomic perturbation data integrated with time-lapse video tracking loops.